Timepoint | Group | Minimum Perfusion | Mean Perfusion | Maximum Perfusion | SD Mean Value |
---|---|---|---|---|---|
Baseline | SSc patients with PAH | 0.164 ± 0.070 | 0.795 ± 0.119 | 2.363 ± 0.429 | 0.292 ± 0.050 |
SSc patients without PAH | 0.169 ± 0.076 | 0.784 ± 0.144 | 2.296 ± 0.523 | 0.282 ± 0.048 | |
Healthy controls | 0.198 ± 0.067 | 0.852 ± 0.187 | 2.786 ± 0.773 | 0.305 ± 0.047 | |
4 weeks | SSc patients with PAH | 0.170 ± 0.066 | 0.800 ± 0.122 | 2.302 ± 0.434 | 0.291 ± 0.047 |
SSc patients without PAH | 0.166 ± 0.072 | 0.781 ± 0.148 | 2.289 ± 0.518 | 0.278 ± 0.043 | |
Healthy controls | 0.190 ± 0.064 | 0.848 ± 0.192 | 2.744 ± 0.7623 | 0.311 ± 0.044 | |
8 weeks | SSc patients with PAH | 0.207 ± 0.084* | 0.911 ± 0.166** | 2.912 ± 0.0512* | 0.313 ± 0.051*** |
SSc patients without PAH | 0.166 ± 0.070 | 0.774 ± 0.184 | 2.294 ± 0.533 | 0.284 ± 0.046 | |
Healthy controls | 0.194 ± 0.063 | 0.858 ± 0.177 | 2.812 ± 0.786 | 0.307 ± 0.048 | |
16 weeks | SSc patients with PAH | 0.210 ± 0.078* | 0.915 ± 0.178** | 2.911 ± 0.522* | 0.333 ± 0.049*** |
SSc patients without PAH | 0.170 ± 0.076 | 0.790 ± 0.144 | 2.290 ± 0.493 | 0.284 ± 0.052 | |
Healthy controls | 0.196 ± 0.059 | 0.860 ± 0.167 | 2.810 ± 0.746 | 0.310 ± 0.050 |